Omnicell, Inc. (OMCL)

Market Cap	1.70B +11.2%
Revenue (ttm)	1.18B +6.5%
Net Income	2.05M -83.6%
EPS	0.04 -85.2%
Shares Out	45.48M
PE Ratio	828.21
Forward PE	21.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	460,833
Open	36.75
Previous Close	36.37
Day's Range	35.50 - 37.52
52-Week Range	22.66 - 55.00
Beta	0.86
Analysts	Buy
Price Target	54.17 (+44.96%)
Earnings Date	Apr 28, 2026

About OMCL

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-hous...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,580
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL
• Website: https://www.omnicell.com

Financial Performance

In 2025, Omnicell's revenue was $1.18 billion, an increase of 6.53% compared to the previous year's $1.11 billion. Earnings were $2.05 million, a decrease of -83.62%.

Analyst Summary

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price target is $54.17, which is an increase of 44.96% from the latest price.

Price Target

$54.17

(44.96% upside)

Analyst Consensus: Buy